You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous T-cell Lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tissue Repository: CTCL Collection Protocol

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
    • New York, New York
      Columbia University Medical Center
    May 2, 2022

    Persistent or Recurrent Cutaneous T-Cell Lymphoma Trial in Australia, Puerto Rico, United States (E7777 9 mcg/kg)

    Completed
    • Persistent or Recurrent Cutaneous T-Cell Lymphoma
    • E7777 9 mcg/kg
    • Birmingham, Alabama
    • +21 more
    Dec 5, 2022

    Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T Cell Lymphoma
    • Guanzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Mar 10, 2023

    Cutaneous T-cell Lymphoma (CTCL) Trial in United Kingdom (CDK-003)

    Recruiting
    • Cutaneous T-cell Lymphoma (CTCL)
    • CDK-003
    • Birmingham, United Kingdom
    • +3 more
    Apr 22, 2022

    Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

    Active, not recruiting
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides/Sezary Syndrome
    • Madrid, Spain
    • +1 more
    Jul 1, 2022

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford, Chicago, Houston (Sapacitabine)

    Terminated
    • Cutaneous T-cell Lymphoma (CTCL)
    • Stanford, California
    • +2 more
    Dec 7, 2021

    Cutaneous T-cell Lymphoma Trial in New York (Bexarotene, Total Skin Electron Beam (TSEB))

    Recruiting
    • Cutaneous T-cell Lymphoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Sep 19, 2022

    Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

    Active, not recruiting
    • Folliculotropic Mycosis Fungoides
    • +7 more
    • Extracorporeal Photopheresis
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

    Active, not recruiting
    • T-Cell Lymphoma
    • +4 more
    • LB1901
    • Rochester, Minnesota
    • +3 more
    Feb 15, 2022

    Characterization of the Microbiome in Cutaneous T Cell Lymphoma

    Recruiting
    • Cutaneous T Cell Lymphoma
      • Chicago, Illinois
        Northwestern University
      Oct 2, 2021

      Hairy Cell and Other Leukemias, and to Develop Recombinant

      Recruiting
      • Hairy Cell Leukemia (HCL)
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

        Recruiting
        • Mantle Cell Lymphoma
        • +9 more
        • L-Bcl-2 antisense oligonucleotide
        • Augusta, Georgia
        • +2 more
        Nov 18, 2022

        Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

        Recruiting
        • Non Hodgkin Lymphoma (NHL)
        • +4 more
        • Orange, California
        • +8 more
        Nov 29, 2022

        Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection Trial in Besançon (Samples collection)

        Recruiting
        • Cutaneous T-Cell Lymphoma
        • +2 more
        • Samples collection
        • Besançon, France
          Centre Hospitalier Universitaire de Besançon
        May 31, 2022

        Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

        Recruiting
        • Recurrent Adult T-Cell Leukemia/Lymphoma
        • +3 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Nov 18, 2022

        Cutaneous T-Cell Lymphoma, Relapsed, Cutaneous T-Cell Lymphoma Refractory Trial in Worldwide (Mogamulizumab)

        Recruiting
        • Cutaneous T-Cell Lymphoma, Relapsed
        • Cutaneous T-Cell Lymphoma Refractory
        • Duarte, California
        • +17 more
        Jul 19, 2022

        Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

        Active, not recruiting
        • Recurrent Anaplastic Large Cell Lymphoma
        • +10 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 30, 2023

        Mapping Emotional Dynamics During Corticosteroid Treatment

        Recruiting
        • Emotions
        • Corticosteroids
        • Short daily questionnaire
        • Leiden, Zuid-Holland, Netherlands
          LUMC
        Aug 30, 2022

        Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With

        Active, not recruiting
        • Cutaneous T Cell Lymphoma
        • Graft Versus Host Disease
          • Lebanon, New Hampshire
            Dartmouth-Hitchcock Medical Center
          Aug 31, 2021

          Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

          Recruiting
          • Cutaneous T-cell Lymphoma
          • +4 more
          • Columbus, Ohio
            The Ohio State University Cancer Center
          Apr 18, 2022

          Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

          Active, not recruiting
          • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
          • Yamagata, Japan
            Yamagata University Hospital
          Feb 21, 2022

          T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

          Completed
          Has Results
          • T-Cell Lymphoma Relapsed
          • +4 more
          • IL-15 plus
          • alemtuzumab
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Apr 27, 2022

          Cutaneous T-Cell Lymphoma Trial in United States (SGX301 (synthetic hypericin), Placebo)

          Completed
          Has Results
          • Cutaneous T-Cell Lymphoma
          • SGX301 (synthetic hypericin)
          • Placebo
          • Birmingham, Alabama
          • +32 more
          Mar 22, 2022

          LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

          Recruiting
          • LGLL - Large Granular Lymphocytic Leukemia
          • +13 more
          • Duarte, California
          • +9 more
          Aug 9, 2022